🇺🇸 FDA
Patent

US 10221235

Endotrophin neutralization and use thereof

granted A61KA61K2039/505A61K31/555

Quick answer

US patent 10221235 (Endotrophin neutralization and use thereof) held by The Board of Regents of the University of Texas System expires Mon Feb 28 2039 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.

Key facts

Applicant
The Board of Regents of the University of Texas System
Grant date
Tue Mar 05 2019 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon Feb 28 2039 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
16
CPC classes
A61K, A61K2039/505, A61K31/555, A61K33/243, A61K39/3955